Autonomix Medical Inc. Co... (AMIX)
Autonomix Medical Common Stock Statistics
Share Statistics
Autonomix Medical Common Stock has 2.46M shares outstanding. The number of shares has increased by -90.6% in one year.
Shares Outstanding | 2.46M |
Shares Change (YoY) | -90.6% |
Shares Change (QoQ) | -92.33% |
Owned by Institutions (%) | n/a |
Shares Floating | 1.94M |
Failed to Deliver (FTD) Shares | 713 |
FTD / Avg. Volume | 0.2% |
Short Selling Information
The latest short interest is 111.64K, so 6.32% of the outstanding shares have been sold short.
Short Interest | 111.64K |
Short % of Shares Out | 6.32% |
Short % of Float | 8.98% |
Short Ratio (days to cover) | 0.15 |
Valuation Ratios
The PE ratio is -2.84 and the forward PE ratio is -0.4. Autonomix Medical Common Stock's PEG ratio is 0.
PE Ratio | -2.84 |
Forward PE | -0.4 |
PS Ratio | 0 |
Forward PS | 0.6 |
PB Ratio | 5.75 |
P/FCF Ratio | -6.58 |
PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Autonomix Medical Inc. Common Stock.
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.09, with a Debt / Equity ratio of 0.13.
Current Ratio | 12.09 |
Quick Ratio | 12.09 |
Debt / Equity | 0.13 |
Total Debt / Capitalization | 11.61 |
Cash Flow / Debt | -6.63 |
Interest Coverage | -94.61 |
Financial Efficiency
Return on equity (ROE) is -2.02% and return on capital (ROIC) is -86.6%.
Return on Equity (ROE) | -2.02% |
Return on Assets (ROA) | -1.64% |
Return on Capital (ROIC) | -86.6% |
Revenue Per Employee | $0 |
Profits Per Employee | $-3,085,200 |
Employee Count | 5 |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -96.95% in the last 52 weeks. The beta is -5.42, so Autonomix Medical Common Stock's price volatility has been lower than the market average.
Beta | -5.42 |
52-Week Price Change | -96.95% |
50-Day Moving Average | 2.58 |
200-Day Moving Average | 10.11 |
Relative Strength Index (RSI) | 35.1 |
Average Volume (20 Days) | 355.15K |
Income Statement
Revenue | n/a |
Gross Profit | -81K |
Operating Income | -7.47M |
Net Income | -15.43M |
EBITDA | -15.27M |
EBIT | n/a |
Earnings Per Share (EPS) | -21.1 |
Balance Sheet
The company has 8.61M in cash and 1M in debt, giving a net cash position of 7.61M.
Cash & Cash Equivalents | 8.61M |
Total Debt | 1M |
Net Cash | 7.61M |
Retained Earnings | -38.97M |
Total Assets | 11.95M |
Working Capital | 9.69M |
Cash Flow
In the last 12 months, operating cash flow was -6.65M and capital expenditures -19K, giving a free cash flow of -6.67M.
Operating Cash Flow | -6.65M |
Capital Expenditures | -19K |
Free Cash Flow | -6.67M |
FCF Per Share | -9.12 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
AMIX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -1146.74% |
FCF Yield | -147.11% |
Analyst Forecast
Currently there are no analyst rating for AMIX.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Scores
Altman Z-Score | -7.01 |
Piotroski F-Score | 4 |